These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30613040)

  • 1. Is the Pace of Biomedical Innovation Slowing?
    Casadevall A
    Perspect Biol Med; 2018; 61(4):584-593. PubMed ID: 30613040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical Innovation: Lessons From the Past and Perspectives for the Future.
    Munos BH
    Clin Pharmacol Ther; 2016 Dec; 100(6):588-590. PubMed ID: 27542985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.
    Stewart SR; Barone PW; Bellisario A; Cooney CL; Sharp PA; Sinskey AJ; Natesan S; Springs SL
    Clin Pharmacol Ther; 2016 Dec; 100(6):647-653. PubMed ID: 27617845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between anesthesia technology innovators, manufacturers, and purchasers.
    Gingles B
    Anesthesiol Clin; 2008 Dec; 26(4):785-92, viii. PubMed ID: 19041629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China.
    Zhang MY; Li J; Hu H; Wang YT
    Health Res Policy Syst; 2015 Nov; 13():64. PubMed ID: 26537659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation in cardiovascular disease in Europe with focus on arrhythmias: current status, opportunities, roadblocks, and the role of multiple stakeholders.
    Prinzen FW; Dagres N; Bollmann A; Arnar DO; Bove S; Camm J; Casadei B; Kirchhof P; Kuck KH; Lumens J; Michel MC; Schwartz PJ; Van Vleymen B; Vardas P; Hindricks G
    Europace; 2018 May; 20(5):733-738. PubMed ID: 28605436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biopharmaceutical industry's commitment to innovation and to the future of health care].
    Marini G
    Recenti Prog Med; 2006 Nov; 97(11):626-33. PubMed ID: 17252719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need.
    Hirsch G; Trusheim M; Cobbs E; Bala M; Garner S; Hartman D; Isaacs K; Lumpkin M; Lim R; Oye K; Pezalla E; Saltonstall P; Selker H
    Clin Pharmacol Ther; 2016 Dec; 100(6):685-698. PubMed ID: 27626610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining innovation.
    Hughes B
    Nat Rev Drug Discov; 2009 Sep; 8(9):683-4. PubMed ID: 19721435
    [No Abstract]   [Full Text] [Related]  

  • 12. [médecine/sciences listening to research].
    Teillaud JL
    Med Sci (Paris); 2020 Jan; 36(1):7-8. PubMed ID: 32014088
    [No Abstract]   [Full Text] [Related]  

  • 13. Top 10 health-care trends for 2003: rising demand, increasing revenues and innovative technologies.
    Coile RC
    Russ Coiles Health Trends; 2003 Jan; 15(3):1, 3-10. PubMed ID: 12553192
    [No Abstract]   [Full Text] [Related]  

  • 14. Can open-source drug R&D repower pharmaceutical innovation?
    Munos B
    Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system].
    Pécoul B
    Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961
    [No Abstract]   [Full Text] [Related]  

  • 16. Fitting places in knowledge translation: Biomedical innovation in healthcare practice.
    Foord D
    Health Policy; 2021 Oct; 125(10):1330-1339. PubMed ID: 34493378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation strategy management survey of the Chilean biomedical industry. Assessment of windows of opportunities to reduce technological gaps.
    Bas TG; Oliu CA
    Int J Health Plann Manage; 2018 Apr; 33(2):e512-e530. PubMed ID: 29423976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safeguarding innovation through an economic downturn.
    Barker R
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):347-9. PubMed ID: 20715908
    [No Abstract]   [Full Text] [Related]  

  • 19. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.